Aprogen Medicines Inc. (007460.KS)
KRW 816.0
(-3.09%)
KRW 816.0
(-3.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 118.79 Billion KRW | -1.42% |
| 2022 | 120.5 Billion KRW | 255.24% |
| 2021 | 33.92 Billion KRW | 11.24% |
| 2020 | 30.49 Billion KRW | 81.63% |
| 2019 | 16.78 Billion KRW | 120.64% |
| 2018 | 7.6 Billion KRW | 208.63% |
| 2017 | 2.46 Billion KRW | -49.43% |
| 2016 | 4.87 Billion KRW | -3.19% |
| 2015 | 5.03 Billion KRW | -14.82% |
| 2014 | 5.91 Billion KRW | 31.3% |
| 2013 | 4.5 Billion KRW | -39.86% |
| 2012 | 7.48 Billion KRW | -79.87% |
| 2011 | 37.19 Billion KRW | 87.99% |
| 2010 | 19.78 Billion KRW | 1.82% |
| 2009 | 19.43 Billion KRW | 8.22% |
| 2008 | 17.95 Billion KRW | 34.48% |
| 2007 | 13.35 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 25.98 Billion KRW | 0.7% |
| 2024 Q1 | 26.19 Billion KRW | -56.92% |
| 2023 Q2 | -9.13 Billion KRW | -134.16% |
| 2023 Q1 | 26.75 Billion KRW | 44.03% |
| 2023 Q3 | -28.48 Billion KRW | -211.73% |
| 2023 FY | 118.79 Billion KRW | -1.42% |
| 2023 Q4 | 60.78 Billion KRW | 313.4% |
| 2022 Q3 | 47.6 Billion KRW | 430.45% |
| 2022 FY | 120.5 Billion KRW | 255.24% |
| 2022 Q1 | 9.61 Billion KRW | 7.01% |
| 2022 Q2 | 8.97 Billion KRW | -6.69% |
| 2022 Q4 | 18.57 Billion KRW | -60.98% |
| 2021 Q3 | 8.6 Billion KRW | -1.25% |
| 2021 Q4 | 8.98 Billion KRW | 4.42% |
| 2021 FY | 33.92 Billion KRW | 11.24% |
| 2021 Q1 | 7.61 Billion KRW | -0.48% |
| 2021 Q2 | 8.71 Billion KRW | 14.53% |
| 2020 Q1 | 7.34 Billion KRW | 4.82% |
| 2020 Q2 | 7.89 Billion KRW | 7.43% |
| 2020 Q3 | 7.56 Billion KRW | -4.15% |
| 2020 Q4 | 7.64 Billion KRW | 1.12% |
| 2020 FY | 30.49 Billion KRW | 81.63% |
| 2019 Q2 | 1.97 Billion KRW | 52.99% |
| 2019 FY | 16.78 Billion KRW | 120.64% |
| 2019 Q1 | 1.28 Billion KRW | -75.23% |
| 2019 Q4 | 7 Billion KRW | 7.48% |
| 2019 Q3 | 6.51 Billion KRW | 230.55% |
| 2018 Q1 | -16.58 Million KRW | 0.0% |
| 2018 Q4 | 5.2 Billion KRW | 271.25% |
| 2018 FY | 7.6 Billion KRW | 208.63% |
| 2018 Q3 | 1.4 Billion KRW | 37.64% |
| 2018 Q2 | 1.01 Billion KRW | 6241.66% |
| 2017 Q1 | 768.15 Million KRW | -63.34% |
| 2017 Q3 | 834.55 Million KRW | 524.68% |
| 2017 FY | 2.46 Billion KRW | -49.43% |
| 2017 Q2 | -196.51 Million KRW | -125.58% |
| 2016 FY | 4.87 Billion KRW | -3.19% |
| 2016 Q2 | 1.48 Billion KRW | 83.8% |
| 2016 Q1 | 807.84 Million KRW | -71.71% |
| 2016 Q3 | 487.43 Million KRW | -67.17% |
| 2016 Q4 | 2.09 Billion KRW | 329.82% |
| 2015 FY | 5.03 Billion KRW | -14.82% |
| 2015 Q4 | 2.85 Billion KRW | 317.22% |
| 2015 Q3 | 684.32 Million KRW | 5.46% |
| 2015 Q2 | 648.89 Million KRW | -23.41% |
| 2015 Q1 | 847.25 Million KRW | -67.08% |
| 2014 Q3 | 1.57 Billion KRW | 66.24% |
| 2014 Q2 | 946.25 Million KRW | 15.58% |
| 2014 Q1 | 818.72 Million KRW | 0.0% |
| 2014 FY | 5.91 Billion KRW | 31.3% |
| 2014 Q4 | 2.57 Billion KRW | 63.62% |
| 2013 Q3 | 1.32 Billion KRW | 25.61% |
| 2013 Q1 | 1.3 Billion KRW | -7.15% |
| 2013 Q4 | - KRW | -100.0% |
| 2013 FY | 4.5 Billion KRW | -39.86% |
| 2013 Q2 | 1.05 Billion KRW | -19.41% |
| 2012 FY | 7.48 Billion KRW | -79.87% |
| 2012 Q1 | 1.4 Billion KRW | 0.0% |
| 2012 Q2 | 2.18 Billion KRW | 55.12% |
| 2012 Q3 | 2.36 Billion KRW | 8.2% |
| 2012 Q4 | 1.4 Billion KRW | -40.5% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 FY | 37.19 Billion KRW | 87.99% |
| 2011 Q1 | 1.33 Billion KRW | 0.0% |
| 2011 Q2 | 1.43 Billion KRW | 7.26% |
| 2011 Q3 | 1.68 Billion KRW | 17.34% |
| 2010 Q3 | 2.39 Billion KRW | 13.96% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q2 | 2.1 Billion KRW | 18.48% |
| 2010 Q1 | 1.77 Billion KRW | 0.0% |
| 2010 FY | 19.78 Billion KRW | 1.82% |
| 2009 Q3 | 1.68 Billion KRW | -17.3% |
| 2009 Q4 | - KRW | -100.0% |
| 2009 Q2 | 2.03 Billion KRW | 9.46% |
| 2009 Q1 | 1.85 Billion KRW | 0.0% |
| 2009 FY | 19.43 Billion KRW | 8.22% |
| 2008 Q1 | 1.22 Billion KRW | 0.0% |
| 2008 Q2 | 1.16 Billion KRW | -5.02% |
| 2008 Q3 | 1.3 Billion KRW | 11.59% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | 17.95 Billion KRW | 34.48% |
| 2007 FY | 13.35 Billion KRW | 0.0% |
| 2007 Q3 | 903.12 Million KRW | -14.22% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 1.05 Billion KRW | 13.52% |
| 2007 Q1 | 927.39 Million KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hwacheon Machine Tool Co. Ltd | 29.76 Billion KRW | -299.071% |
| SIMPAC Inc. | 42.06 Billion KRW | -182.42% |
| Kyung Dong Navien Co., Ltd. | 370.99 Billion KRW | 67.978% |
| Korea Shipbuilding & Offshore Engineering Co., Ltd. | 727.41 Billion KRW | 83.669% |
| Korea Refractories Co., Ltd | 43.33 Billion KRW | -174.129% |
| Woojin I&S Co., Ltd. | 7.46 Billion KRW | -1490.36% |
| Hwacheon Machinery Co., Ltd. | 16.77 Billion KRW | -608.324% |
| Hanshin Machinery Co., Ltd. | 7.85 Billion KRW | -1412.889% |
| STX Corporation | 48.24 Billion KRW | -146.222% |
| Curo Co.,Ltd. | 16.11 Billion KRW | -637.283% |
| Hyundai Elevator Co., Ltd | 356.27 Billion KRW | 66.656% |
| Doosan Enerbility Co., Ltd. | 1518.46 Billion KRW | 92.176% |
| Woojin Plaimm Co., Ltd. | 49.77 Billion KRW | -138.679% |
| STX Heavy Industries Co., Ltd. | 36.24 Billion KRW | -227.717% |
| STX Engine Co.,Ltd. | 47.45 Billion KRW | -150.352% |
| HSD Engine Co., Ltd. | 32.42 Billion KRW | -266.415% |
| NK Co., Ltd. | 14.43 Billion KRW | -723.144% |
| SNT Energy Co., Ltd. | 28.49 Billion KRW | -316.97% |
| CS Wind Corporation | 70.21 Billion KRW | -69.194% |
| Dynamic Design Co., LTD. | 16.13 Billion KRW | -636.127% |
| HD Hyundai Co., Ltd. | 2628.5 Billion KRW | 95.48% |
| Hyosung Heavy Industries Corporation | 340.99 Billion KRW | 65.162% |
| LG Energy Solution, Ltd. | 2517.62 Billion KRW | 95.281% |